| GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 1 |
AVPR1B |
AVPR1B, AVPR3, VPR3: Vasopressin V1b receptor |
0.417 |
Evidence |
|
| GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 1 |
OPRD1 |
OPRD1, OPRD: Delta-type opioid receptor |
0.417 |
Evidence |
O
|
| GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 1 |
AVPR1A |
AVPR1A, AVPR1: Vasopressin V1a receptor |
0.417 |
Evidence |
|
| GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 1 |
OXTR |
OXTR: Oxytocin receptor |
0.417 |
Evidence |
|
| GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 1 |
AVPR2 |
AVPR2, ADHR, DIR, DIR3, V2R: Vasopressin V2 receptor |
0.417 |
Evidence |
|
| F7 |
F7: Coagulation factor VII precursor |
CDO1 |
CDO1: Cysteine dioxygenase type 1 |
0.417 |
Evidence |
|
| HCK |
IPI00029769 |
EPHA5 |
EPHA5, EHK1, HEK7: Ephrin type-A receptor 5 precursor |
0.417 |
Evidence |
|
| RET |
RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor |
VDP |
DKFZp451D234: Putative uncharacterized protein DKFZp451D234 |
0.417 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
ALK |
ALK: ALK tyrosine kinase receptor precursor |
0.417 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
EPHA5 |
EPHA5, EHK1, HEK7: Ephrin type-A receptor 5 precursor |
0.417 |
Evidence |
|
| TIMP1 |
TIMP1, CLGI, TIMP: Metalloproteinase inhibitor 1 precursor |
LTA4H |
LTA4H, LTA4: Leukotriene A-4 hydrolase |
0.417 |
Evidence |
|
| TIMP1 |
TIMP1, CLGI, TIMP: Metalloproteinase inhibitor 1 precursor |
NLN |
NLN, AGTBP, KIAA1226: Neurolysin, mitochondrial precursor |
0.417 |
Evidence |
|
| GRAP2 |
GRAP2, GADS, GRB2L, GRID: GRB2-related adapter protein 2 |
EPHA5 |
EPHA5, EHK1, HEK7: Ephrin type-A receptor 5 precursor |
0.417 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
EPHA5 |
EPHA5, EHK1, HEK7: Ephrin type-A receptor 5 precursor |
0.417 |
Evidence |
|
| KCNQ2 |
KCNQ2: Potassium voltage-gated channel subfamily KQT member 2 |
MCOLN1 |
MCOLN1, ML4, MSTP080: Mucolipin-1 |
0.417 |
Evidence |
|
| KCNQ2 |
KCNQ2: Potassium voltage-gated channel subfamily KQT member 2 |
TRPM7 |
TRPM7, CHAK1, LTRPC7: Transient receptor potential cation channel subfamily M me |
0.417 |
Evidence |
|
| KCNQ2 |
KCNQ2: Potassium voltage-gated channel subfamily KQT member 2 |
KCTD12 |
KCTD12, C13orf2, KIAA1778, PFET1: BTB/POZ domain-containing protein KCTD12 |
0.417 |
Evidence |
|
| UTX |
UTX: Ubiquitously transcribed X chromosome tetratricopeptide repeat protein |
F7 |
F7: Coagulation factor VII precursor |
0.417 |
Evidence |
|
| APS |
SH2B2, APS: SH2B adapter protein 2 |
EPHA5 |
EPHA5, EHK1, HEK7: Ephrin type-A receptor 5 precursor |
0.417 |
Evidence |
|
| PIK3R2 |
PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta |
EPHA5 |
EPHA5, EHK1, HEK7: Ephrin type-A receptor 5 precursor |
0.417 |
Evidence |
|
| GRB10 |
IPI00012752 |
SHC3 |
SHC3, NSHC, SHCC: SHC-transforming protein 3 |
0.417 |
Evidence |
|
| DUSP2 |
DUSP2, PAC1: Dual specificity protein phosphatase 2 |
GRB10 |
IPI00012752 |
0.417 |
Evidence |
|
| BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
DOK4 |
DOK4: Docking protein 4 |
0.417 |
Evidence |
|
| BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
ANKK1 |
ANKK1, PKK2, SGK288: Ankyrin repeat and protein kinase domain-containing protein |
0.417 |
Evidence |
|
| BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
STYK1 |
STYK1, NOK: Tyrosine protein-kinase STYK1 |
0.417 |
Evidence |
|